We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-12.39%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$945M
AUM Growth
–
Cap. Flow
+$1.07B
Cap. Flow %
113.47%
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$376M
2
EQRX
EQRx, Inc. Common Stock
EQRX
+$343M
3
ERAS icon
Erasca
ERAS
+$189M
4
VERV
Verve Therapeutics
VERV
+$105M
5
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$49.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$382M 40.37%
+2,912,872
New +$376M
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$248M 26.22%
+36,335,375
New +$343M
ERAS icon
3
Erasca
ERAS
$6.66B
$172M 18.22%
+11,055,554
New +$189M
VERV
4
DELISTED
Verve Therapeutics
VERV
$92.5M 9.79%
+2,508,809
New +$105M
OMIC
5
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$43.9M 4.65%
+126,631
New +$49.1M
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
$3.39M 0.36%
+349,908
New +$4.85M
NTRA icon
7
Natera
NTRA
$38.1B
$3M 0.32%
+32,098
New +$3.33M
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
$797K 0.08%
+119,205
New +$1.16M
PULM icon
9
Pulmatrix
PULM
$6.5M
$19K ﹤0.01%
+2,182
New +$29.8K

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Arch Venture Management, which disclosed 9 positions worth $945M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Karuna Therapeutics, Inc. Common Stock: 2,912,872 shares worth $382M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Arch Venture Management's largest Q4 2021 buy was Karuna Therapeutics, Inc. Common Stock: 2,912,872 shares worth $382M.
  • Arch Venture Management's ten largest holdings make up 100% of its $945M portfolio in Q4 2021.
  • Arch Venture Management disclosed 9 positions in Q4 2021, its first 13F filing on record.

Based on Arch Venture Management's 13F filing for Q4 2021, filed 14 Feb 2022.